1
|
Mai N, Knowlden SA, Miller-Rhodes K, Prifti V, Sims M, Grier M, Nelson M, Halterman MW. Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injury. Exp Mol Pathol 2020; 118:104601. [PMID: 33385413 DOI: 10.1016/j.yexmp.2020.104601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2020] [Revised: 11/24/2020] [Accepted: 12/26/2020] [Indexed: 11/26/2022]
Abstract
Cerebral ischemia triggers a cascade of neuroinflammatory and peripheral immune responses that contribute to post-ischemic reperfusion injury. Prior work conducted in CNS ischemia models underscore the potential to harness non-antibiotic properties of tetracycline antibiotics for therapeutic benefit. In the present study, we explored the immunomodulatory effects of the tetracycline derivative 9-tert-butyl doxycycline (9-TB) in a mouse model of transient global ischemia that mimics immunologic aspects of the post-cardiac arrest syndrome. Pharmacokinetic studies performed in C57BL/6 mice demonstrate that within four hours after delivery, levels of 9-TB in the brain were 1.6 and 9.5-fold higher than those obtained using minocycline and doxycycline, respectively. Minocycline and 9-TB also dampened inflammation, measured by reduced TNFα-inducible, NF-κβ-dependent luciferase activity in a microglial reporter line. Notably, daily 9-TB treatment following ischemia-reperfusion injury in vivo induced the retention of polymorphonuclear neutrophils (PMNs) within the spleen while simultaneously biasing CNS PMNs towards an anti-inflammatory (CD11bLowYm1+) phenotype. These studies indicate that aside from exhibiting enhanced CNS delivery, 9-TB alters both the trafficking and polarization of PMNs in the context of CNS ischemia-reperfusion injury.
Collapse
Affiliation(s)
- Nguyen Mai
- Department of Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USA; The Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA
| | - Sara A Knowlden
- Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA; The Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA
| | - Kathleen Miller-Rhodes
- Department of Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USA; The Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA
| | - Viollandi Prifti
- Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA; The Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA
| | - Max Sims
- Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA; The Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA
| | - Mark Grier
- Echelon Biosciences, Salt Lake City, UT 84108, USA
| | - Mark Nelson
- Echelon Biosciences, Salt Lake City, UT 84108, USA
| | - Marc W Halterman
- Department of Neurology, SUNY Stony Brook, Stony Brook, NY, USA.
| |
Collapse
|
2
|
Furlan G, Cuccioli V, Vuillemin N, Dirian L, Muntasell AJ, Coolen M, Dray N, Bedu S, Houart C, Beaurepaire E, Foucher I, Bally-Cuif L. Life-Long Neurogenic Activity of Individual Neural Stem Cells and Continuous Growth Establish an Outside-In Architecture in the Teleost Pallium. Curr Biol 2017; 27:3288-3301.e3. [PMID: 29107546 PMCID: PMC5678050 DOI: 10.1016/j.cub.2017.09.052] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2017] [Revised: 08/14/2017] [Accepted: 09/25/2017] [Indexed: 01/08/2023]
Abstract
Spatiotemporal variations of neurogenesis are thought to account for the evolution of brain shape. In the dorsal telencephalon (pallium) of vertebrates, it remains unresolved which ancestral neurogenesis mode prefigures the highly divergent cytoarchitectures that are seen in extant species. To gain insight into this question, we developed genetic tools to generate here the first 4-dimensional (3D + birthdating time) map of pallium construction in the adult teleost zebrafish. Using a Tet-On-based genetic birthdating strategy, we identify a “sequential stacking” construction mode where neurons derived from the zebrafish pallial germinal zone arrange in outside-in, age-related layers from a central core generated during embryogenesis. We obtained no evidence for overt radial or tangential neuronal migrations. Cre-lox-mediated tracing, which included following Brainbow clones, further demonstrates that this process is sustained by the persistent neurogenic activity of individual pallial neural stem cells (NSCs) from embryo to adult. Together, these data demonstrate that the spatiotemporal control of NSC activity is an important driver of the macroarchitecture of the zebrafish adult pallium. This simple mode of pallium construction shares distinct traits with pallial genesis in mammals and non-mammalian amniotes such as birds or reptiles, suggesting that it may exemplify the basal layout from which vertebrate pallial architectures were elaborated. Neurons of the teleost pallium are arranged in concentric age-dependent layers Neurons of the central pallial domain, Dc, are born during embryogenesis Most pallial neurons are generated from ventricular her4-positive radial glia The majority of individual pallial radial glia are neurogenic throughout life
Collapse
Affiliation(s)
- Giacomo Furlan
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France
| | - Valentina Cuccioli
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France; Unit Zebrafish Neurogenetics, Developmental and Stem Cell Biology Department, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France; CNRS UMR 3738, 25 Rue du Dr. Roux, 75015 Paris, France
| | - Nelly Vuillemin
- Laboratory for Optics and Biosciences, École Polytechnique, CNRS UMR 7645 and INSERM U1182, 91128 Palaiseau, France
| | - Lara Dirian
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France
| | - Anna Janue Muntasell
- Centre for Developmental Neurobiology and MRC Centre for Neurodevelopmental Disorders, IoPPN, King's College London, London SE1 1UL, UK
| | - Marion Coolen
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France; Unit Zebrafish Neurogenetics, Developmental and Stem Cell Biology Department, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France; CNRS UMR 3738, 25 Rue du Dr. Roux, 75015 Paris, France
| | - Nicolas Dray
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France; Unit Zebrafish Neurogenetics, Developmental and Stem Cell Biology Department, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France; CNRS UMR 3738, 25 Rue du Dr. Roux, 75015 Paris, France
| | - Sébastien Bedu
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France; Unit Zebrafish Neurogenetics, Developmental and Stem Cell Biology Department, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France; CNRS UMR 3738, 25 Rue du Dr. Roux, 75015 Paris, France
| | - Corinne Houart
- Centre for Developmental Neurobiology and MRC Centre for Neurodevelopmental Disorders, IoPPN, King's College London, London SE1 1UL, UK
| | - Emmanuel Beaurepaire
- Laboratory for Optics and Biosciences, École Polytechnique, CNRS UMR 7645 and INSERM U1182, 91128 Palaiseau, France
| | - Isabelle Foucher
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France; Unit Zebrafish Neurogenetics, Developmental and Stem Cell Biology Department, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France; CNRS UMR 3738, 25 Rue du Dr. Roux, 75015 Paris, France.
| | - Laure Bally-Cuif
- Team Zebrafish Neurogenetics, Paris-Saclay Institute for Neuroscience (Neuro-PSI), UMR 9197, CNRS-Université Paris-Sud, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France; Unit Zebrafish Neurogenetics, Developmental and Stem Cell Biology Department, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France; CNRS UMR 3738, 25 Rue du Dr. Roux, 75015 Paris, France.
| |
Collapse
|
3
|
Hsu WM, Huang CC, Lee HY, Wu PY, Wu MT, Chuang HC, Lin LL, Chuang JH. MDA5 complements TLR3 in suppression of neuroblastoma. Oncotarget 2015; 6:24935-46. [PMID: 26208481 PMCID: PMC4694805 DOI: 10.18632/oncotarget.4511] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2015] [Accepted: 06/26/2015] [Indexed: 12/28/2022] Open
Abstract
Toll-like receptor3 (TLR3) has been confirmed to be differentially expressed in neuroblastoma (NB), and predicts a favorable prognosis with a high expression in tumor tissues. Treatment with TLR3 agonist--polyinosinic-polycytidylic acid [poly(I:C)] could induce significant but limited apoptosis in TLR3-expressing NB cells, suggesting that other viral RNA sensors, including melanoma differentiation-associated gene 5 (MDA5) and retinoic acid-inducible gene-I (RIG-I) in the cytosolic compartment might also be implicated in poly(I:C)-induced NB cell death. MDA5 and RIG-I were induced by poly(I:C) to express in two of six NB cell lines, SK-N-AS (AS) and SK-N-FI, which were associated with up-regulation of caspase9 and active caspase3. While knockdown of either MDA5 or RIG-I alone is ineffective to decrease caspase9 and active caspase3, simultaneously targeting MDA5 and TLR3 showed the best effect to rescue poly(I:C) induced up-regulation of mitochondrial antiviral signaling protein (MAVS), caspase9, active caspase3, and apoptosis in AS cells. Over-expression of MDA5 in FaDu cells resulted in significantly less colony formation and more poly(I:C)-induced cell death. Further studies in human NB tissue samples revealed that MDA5 expression in NB tissues predicted a favorable prognosis synergistically with TLR3. Our findings indicate that MDA5 may serve as a complementary role in the TLR3 activated suppression of NB.
Collapse
Affiliation(s)
- Wen-Ming Hsu
- Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
| | - Chao-Cheng Huang
- Department of Pathology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
| | - Hsin-Yu Lee
- Department of Life Science and Institute of Zoology, National Taiwan University, Taipei, Taiwan
| | - Pei-Yi Wu
- Department of Life Science and Institute of Zoology, National Taiwan University, Taipei, Taiwan
| | - Min-Tsui Wu
- Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
| | - Hui-Ching Chuang
- Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
| | - Li-Ling Lin
- Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
- Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
| | - Jiin-Haur Chuang
- Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
| |
Collapse
|
4
|
Jiang D, Nelson ML, Gally F, Smith S, Wu Q, Minor M, Case S, Thaikoottathil J, Chu HW. Airway epithelial NF-κB activation promotes Mycoplasma pneumoniae clearance in mice. PLoS One 2012; 7:e52969. [PMID: 23285237 PMCID: PMC3532414 DOI: 10.1371/journal.pone.0052969] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2012] [Accepted: 11/07/2012] [Indexed: 01/27/2023] Open
Abstract
BACKGROUND/OBJECTIVE Respiratory infections including atypical bacteria Mycoplasma pneumoniae (Mp) contribute to the pathobiology of asthma and chronic obstructive pulmonary disease (COPD). Mp infection mainly targets airway epithelium and activates various signaling pathways such as nuclear factor κB (NF-κB). We have shown that short palate, lung, and nasal epithelium clone 1 (SPLUNC1) serves as a novel host defense protein and is up-regulated upon Mp infection through NF-κB activation in cultured human and mouse primary airway epithelial cells. However, the in vivo role of airway epithelial NF-κB activation in host defense against Mp infection has not been investigated. In the current study, we investigated the effects of in vivo airway epithelial NF-κB activation on lung Mp clearance and its association with airway epithelial SPLUNC1 expression. METHODOLOGY/MAIN RESULTS Non-antimicrobial tetracycline analog 9-t-butyl doxycycline (9-TB) was initially optimized in mouse primary tracheal epithelial cell culture, and then utilized to induce in vivo airway epithelial specific NF-κB activation in conditional NF-κB transgenic mice (CC10-(CA)IKKβ) with or without Mp infection. Lung Mp load and inflammation were evaluated, and airway epithelial SPLUNC1 protein was examined by immunohistochemistry. We found that 9-TB treatment in NF-κB transgene positive (Tg+), but not transgene negative (Tg-) mice significantly reduced lung Mp load. Moreover, 9-TB increased airway epithelial SPLUNC1 protein expression in NF-κB Tg+ mice. CONCLUSION By using the non-antimicrobial 9-TB, our study demonstrates that in vivo airway epithelial NF-κB activation promotes lung bacterial clearance, which is accompanied by increased epithelial SPLUNC1 expression.
Collapse
Affiliation(s)
- Di Jiang
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Mark L. Nelson
- Department of Immunology, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Fabienne Gally
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Sean Smith
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Qun Wu
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Maisha Minor
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Stephanie Case
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Jyoti Thaikoottathil
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
| | - Hong Wei Chu
- Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, Colorado, United States of America
- Business and Science Development, Echelon Biosciences Inc., Salt Lake City, Utah, United States of America
- * E-mail:
| |
Collapse
|
5
|
Fuoco D. Classification Framework and Chemical Biology of Tetracycline-Structure-Based Drugs. Antibiotics (Basel) 2012; 1:1-13. [PMID: 27029415 PMCID: PMC4790241 DOI: 10.3390/antibiotics1010001] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2012] [Revised: 05/21/2012] [Accepted: 06/08/2012] [Indexed: 12/27/2022] Open
Abstract
By studying the literature about tetracyclines (TCs), it becomes clearly evident that TCs are very dynamic molecules. In some cases, their structure-activity-relationship (SAR) are well known, especially against bacteria, while against other targets, they are virtually unknown. In other diverse fields of research-such as neurology, oncology and virology-the utility and activity of the tetracyclines are being discovered and are also emerging as new technological fronts. The first aim of this paper is to classify the compounds already used in therapy and prepare the schematic structure that includes the next generation of TCs. The second aim of this work is to introduce a new framework for the classification of old and new TCs, using a medicinal chemistry approach to the structure of those drugs. A fully documented Structure-Activity-Relationship (SAR) is presented with the analysis data of antibacterial and nonantibacterial (antifungal, antiviral and anticancer) tetracyclines. The lipophilicity and the conformational interchangeability of the functional groups are employed to develop the rules for TC biological activity.
Collapse
Affiliation(s)
- Domenico Fuoco
- Italian National Board of Chemists and Italian Chemical Society, Rome, 00187, Italy.
- McGill Nutrition and Performance Laboratory, Department of Oncology, School of Medicine, McGill University, 5252 Maisonneuve Street, Montreal, QC, H4A3S5, Canada.
| |
Collapse
|
6
|
Rininger A, Dejesus C, Totten A, Wayland A, Halterman MW. MKP-1 antagonizes C/EBPβ activity and lowers the apoptotic threshold after ischemic injury. Cell Death Differ 2012; 19:1634-43. [PMID: 22522596 DOI: 10.1038/cdd.2012.41] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
The dual specificity phosphatase MAPK phosphatase-1 (MKP-1) feeds back on MAP kinase signaling to regulate metabolic, inflammatory and survival responses. MKP-1 is widely expressed in the central nervous system (CNS) and induced after ischemic stress, although its function in these contexts remains unclear. Here we report that MKP-1 activated several cell death factors, including BCL2 and adenovirus E1B 19 kDa interacting protein 3, and caspases 3 and 12 culminating in apoptotic cell death in vitro. MKP-1 also exerted inhibitory effects on the bZIP transcription factor CCAAT/enhancer-binding protein (C/EBPβ), previously shown to have neuroprotective properties. These effects included reduced expression of the full-length C/EBPβ variant and hypo-phosphorylation at the MEK-ERK1/2-sensitive Thr(188) site. Notably, enforced expression C/EBPβ rescued cells from MKP-1-induced toxicity. Studies performed in knock-out mice indicate that the MKP-1 activity is required to exclude C/EBPβ from the nucleus basally, and that MKP-1 antagonizes C/EBPβ expression after global forebrain ischemia, particularly within the vulnerable CA1 sector of the hippocampus. Overall, MKP-1 appears to lower the cellular apoptotic threshold by inhibiting C/EBPβ and enhancing both BH3 protein expression and cellular caspase activity. Thus, although manipulation of the MKP-1-C/EBPβ axis could have therapeutic value in ischemic disorders, our observations using MKP-1 catalytic mutants suggest that approaches geared towards inhibiting MKP-1's phosphatase activity alone may be ineffective.
Collapse
Affiliation(s)
- A Rininger
- Department of Pediatrics, University of Rochester Medical Center, NY, USA
| | | | | | | | | |
Collapse
|